Quit Allergy Shots? Here's What to Do Next (Without Starting Over)

Quick Answer

You didn't fail — 77% of allergy shot patients discontinue before the 3-year minimum, with a median duration of only 1.7 years (Kiel 2013, JACI, N=6,486). You can safely transition from shots to sublingual drops at standard dose (Brazilian ASBAI 2024; Pajno 2013, N=9,218). Important honesty: SLIT real-world completion rates are actually lower than shots — 7% versus 23% at 3 years. The convenience of home use doesn't automatically fix adherence.

Quick Facts

Detail	Info
Shot dropout rate	77% before 3 years; median 1.7 years (Kiel 2013, N=6,486)
SLIT dropout rate	93% before 3 years; only 7% complete (Kiel 2013)
SCIT→SLIT switch	Safe and feasible at standard SLIT dose (ASBAI 2024; Pajno 2013)
Drops vs shots efficacy	No significant difference for standardized products (Tie 2022, 46 RCTs)
Minimum for lasting benefit	3 years (GRASS trial confirmed 2 years insufficient)
Monthly cost of allergy drops	$39–99/month depending on insurance (2026)

"I Quit Allergy Shots After a Few Months — Have I Wasted Everything?"

You started with good intentions. Weekly visits. The drive to the clinic. The wait. The injection. The 30-minute observation period. At first you kept the schedule. Then work got busy. A missed week became two. The receptionist's voicemail went unreturned. And quietly, you just... stopped going.

Now your allergies are back — maybe worse than before — and you feel like you failed at the one treatment that was supposed to fix things permanently. The guilt sits alongside the congestion, the disrupted sleep, the daily antihistamine that barely takes the edge off.

Here's what no one told you: 77% of shot patients quit before completing the 3-year minimum. The median duration is 1.7 years. Top reasons: time commitment, needle discomfort, cost, and reactions. You're in the majority, not the exception.

Why Most People Can't Finish Allergy Shots

Step 1 — The commitment is extraordinary. A full allergy shot course requires 80–100 total clinic visits over 5 years: 26–40 weekly build-up visits, then 48–54 monthly maintenance visits. Each visit means travel, wait time, injection, and 30-minute post-injection observation. At average US wage of $37.32/hour (BLS Feb 2026), the time cost alone approaches $3,500 over 5 years.

Step 2 — Early quitting erases the benefit. The GRASS trial (Scadding 2017, JAMA, N=106) definitively proved that 2 years of immunotherapy is insufficient — neither shots nor drops maintained benefit 1 year after stopping a 2-year course. Three years is the minimum for lasting immune modification. If you quit at the median 1.7 years, you likely didn't reach the threshold for persistent benefit.

Step 3 — The same immune mechanism works through drops. Both shots and drops retrain your immune system through the same pathway — shifting from allergic (TH2) to tolerant (TH1/Treg). For standardized products, the most recent meta-analysis shows no significant efficacy difference (Tie 2022, 46 RCTs: symptom SMD −0.02, medication −0.14). Drops are dramatically safer: zero fatalities worldwide across 1+ billion doses versus 1 per 7.2 million for shots (Epstein 2021).

What To Do Next

1. Stop feeling guilty — and start evaluating what went wrong. Was it time? Needles? Cost? Reactions? Each barrier has a specific solution. If time killed your shot schedule, at-home drops eliminate clinic visits entirely. If cost was the issue, know that 5-year drop cost ($6,000–8,500) is typically less than 5-year shot cost ($8,000–20,000 uninsured).

2. Talk to your provider about transitioning. SCIT-to-SLIT switching is described as "very easy and safe" — drops can start at standard dose without repeating build-up (Brazilian ASBAI 2024; Pajno 2013 confirmed feasibility in 9,218 children). You don't start from zero.

3. A 3-minute allergy quiz can match you with an at-home immunotherapy plan. Drops are taken at home in 2 minutes daily — no needles, no clinic visits, no observation periods. Cost: $39–99/month (2026).

When Going Back to Shots Might Be Better

If you quit shots because of a severe allergic reaction (not logistics), ask whether the same risk applies to drops. Drops are dramatically safer, but your reaction history matters.

If your insurance covers shots at $0 copay and your allergist is nearby — shots may actually be more practical. The financial case for drops depends on your specific insurance situation.

Most importantly: SLIT completion rates are actually worse than SCIT in real-world data. Only 7% of SLIT patients completed 3 years versus 23% of SCIT patients (Kiel 2013, N=6,486). German data confirms: 37.5% SCIT persistence at 3 years versus 9.6–13.4% SLIT (Vogelberg 2020). The convenience of home use removes clinic accountability — and for some people, that accountability is what keeps them on track.

If you quit shots because of motivation rather than logistics, drops alone won't fix that. The daily habit of unsupervised home treatment requires more self-discipline than showing up for a scheduled appointment. Be honest with yourself about what kind of accountability structure you need.

Related Issues to Check

• Allergy drops vs allergy shots: the complete comparison — The head-to-head evidence across 46 RCTs, including the honest adherence data showing shots actually have better completion rates. The best treatment is the one you'll complete for 3+ years.

• What happens if you stop immunotherapy early? — The specific immune consequences of quitting at each time point. Two years: definitively insufficient. Three years: benefits persist 7+ years. Understanding what you lost (and what you didn't) helps frame the restart decision.

• How long until allergy drops work? — If you completed any portion of shots, you have some immune modification. The timeline for drops starts from wherever your immune system currently sits — IgG4 at 4–8 weeks, symptom improvement at 3–6 months, medication-free at year 3 for 43.6% of patients.

Frequently Asked Questions

Can I switch from shots to drops without starting over? Yes. SCIT-to-SLIT switching is safe and feasible at standard SLIT dose without repeating build-up (Brazilian ASBAI 2024; Pajno 2013, N=9,218 children). However, SLIT-to-SCIT switching requires caution and dose reduction.

Did I waste my time on shots if I quit at 1 year? Partially. You built some immune modification, but the GRASS trial proved 2 years is insufficient for lasting benefit (Scadding 2017, JAMA). Some residual immune tolerance may remain, but it likely won't persist without completing at least 3 years total.

Are drops really as effective as shots? For standardized products, yes. The most recent meta-analysis (Tie 2022, 46 RCTs) found no significant difference. The 2025 US practice parameter states: "near equivalent efficacy, but SLIT has a superior safety profile" (Bernstein 2025).

Why are SLIT completion rates worse than shots? Home use eliminates the accountability of scheduled clinic visits. When no one notices if you skip a day, it's easier to lapse. Pharmacy data shows median SLIT duration of 0.6 years versus 1.7 years for SCIT (Kiel 2013). Building a consistent daily habit is the key to SLIT success.

What if I can't commit to 3 years of anything? Then medication management may be your best option. Intranasal corticosteroid plus fexofenadine provides the best symptom control short of immunotherapy. Generic cetirizine costs $10.49/year. Immunotherapy is a serious commitment for a serious problem — not for mild seasonal allergies managed by one daily pill.

Last reviewed: March 2026 · Sources verified against current data

Medically reviewed by Dr. Chet Tharpe, MD · March 2026

Take the Next Step

If you quit allergy shots and want to explore whether at-home drops can finish what you started, a 3-minute allergy quiz identifies your triggers and matches you with a treatment plan.

Take the free 3-minute allergy quiz →